Skip to main content
OpenTrials
Completed

NCT Number: NCT01870531

Korean Transient Ischemic Attack eXpression Registry

This study is to determine the clinical and neuroimaging characteristics of Transient Ischemic Attacks in Korean populations.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Boramae Hospital

Seoul, 156-707, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical symptoms and signs consistent with transient ischemic attack
  • Subject who admitted hospital within 24 hours after symptom onset
  • Subjects who underwent MRI (including diffusion-weighted images) and MRA (or CT angiography)

Exclusion criteria

Transient neurological symptoms due to

  • Migraine aura
  • Basilar migraine
  • Seizures
  • Syncope
  • Peripheral vertigo
  • Transient global amnesia

Treatment and study plan

Primary outcomes

  1. Vascular events including ischemic strokes, myocardial infarctions, cardiovascular deaths

    Time frame: 90 days

Secondary outcomes

  1. Recurrent transient ischemic attacks

    Time frame: 90 days

Sponsors and collaborators

Lead sponsor

Seoul National University Boramae Hospital

Other

Registry information

Official study title

Transient Ischemic Attacks in Korean: Hospital-based, Multi-center Prospective Registry

Acronym: KTX registry

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Jun 6, 2013
Registry last updated
Jun 9, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.